Eloquent

AbCellera Biologics (Long hold)

Long
NASDAQ:ABCL   AbCellera Biologics Inc.
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera's full-stack, Artificial Intelligence-powered drug discovery platform integrates modern technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development.

Imagine a world where artificial intelligence could find the cure to any disease. That's what this company is all about.

the chart might not be the prettiest, but their mission is one I am willing to invest in.

-------

$37 is my conservative target from the current levels, and it's very possible we make a few more lower lows, but ultimately I think this company has a very bright future despite the recent beat downs.

If and when we reach $37, I'd like to re-evaluate my analysis, & deep dive into the wave structure which brought us there. If it looks clean, then new projections can be made.

💸

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.